Unknown

Dataset Information

Urine nicotine metabolite concentrations in relation to plasma cotinine during low-level nicotine exposure.


ABSTRACT:

Introduction

Plasma or saliva cotinine concentrations are used widely as biomarkers of secondhand smoke (SHS) exposure and have been associated with the risk of SHS-related disease. Concentrations of cotinine and other nicotine metabolites are considerably higher in urine than in plasma or saliva, making chemical analysis easier. In addition, urine is often more convenient to collect in some SHS exposure studies. The optimal use of nicotine metabolites in urine, singly or in combination, with or without correction for urine creatinine concentration, to estimate plasma cotinine concentration with low-level nicotine exposure has not been determined.

Methods

We dosed 36 nonsmokers with 100, 200, or 400 microg deuterium-labeled nicotine (simulating exposure to SHS) by mouth dail

SUBMITTER: Benowitz NL 

PROVIDER: S-EPMC2734286 | biostudies-literature | 2009 Aug

REPOSITORIES: biostudies-literature